SOTAC PHARMACEUTICALS
Back to Cashflow Statement
|
SOTAC PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹-4.33 Cr | ₹-16 Cr | ₹8.14 Cr | ₹6.35 Cr | ₹-0.31 Cr |
What is the latest Cash Flow from Operating Activities ratio of SOTAC PHARMACEUTICALS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹-4.33 Cr |
| Mar2024 | ₹-16 Cr |
| Mar2023 | ₹8.14 Cr |
| Mar2022 | ₹6.35 Cr |
| Mar2021 | ₹-0.31 Cr |
How is Cash Flow from Operating Activities of SOTAC PHARMACEUTICALS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-4.33 Cr | Negative | |
| Mar2024 | ₹-16 Cr | Negative | |
| Mar2023 | ₹8.14 Cr | 28.22 | |
| Mar2022 | ₹6.35 Cr | Positive | |
| Mar2021 | ₹-0.31 Cr | - | |
Compare Cash Flow from Operating Activities of peers of SOTAC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SOTAC PHARMACEUTICALS | ₹129.9 Cr | 15.6% | 3.6% | -11.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹401,937.0 Cr | 1.2% | -7% | 2.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹165,359.0 Cr | 1.8% | 2.7% | 17% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,431.0 Cr | 0.5% | -4.8% | 32.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,114.0 Cr | 0.3% | -4.5% | 11.5% | Stock Analytics | |
| CIPLA | ₹100,028.0 Cr | 0.7% | -5.8% | -13.1% | Stock Analytics | |
SOTAC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SOTAC PHARMACEUTICALS | 15.6% |
3.6% |
-11.1% |
| SENSEX | 2.4% |
3.2% |
5.8% |
You may also like the below Video Courses